Breakthrough Lyme Disease Test is the "Next Generation" of Diagnostics; Crowd Funding Campaign Launches to Start Clinical Study
A new test for Lyme Disease may prove to be the most accurate tool available for the difficult-to-diagnose disease, giving hope to thousands of undiagnosed and misdiagnosed patients, if funding can be found to move it through clinical study to production.
Dr. Keim Named Fellow of the American Association for the Advancement of Science
Dr. Paul Keim, Director of the Pathogen Genomics Division of the Translational Genomics Research Institute (TGen) and the Cowden Endowed Chair of Microbiology at Northern Arizona University (NAU), has been named a Fellow of the American Association for the Advancement of Science (AAAS).
A chance airline encounter between TGen’s Physician-in-Chief, Dr. Daniel Von Hoff, and the mother of a young woman with Lyme disease has led TGen’s Pathogen Genomics Division to begin development of a new and exacting test for this debilitating illness that affects nearly 300,000 Americans each year.
TGen Developing Quick, Affordable and Accurate Test to Diagnose Debilitating Lyme Disease
Focus On Lyme, an initiative sponsored by the Leadership Children’s Foundation of Gilbert, Ariz., has donated $75,000 to the Translational Genomics Research Institute (TGen) to support research into the development of a quick, affordable and accurate method of diagnosing Lyme disease.